Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$485K Buy
7,723
+21
+0.3% +$1.46K 0.01% 609
2025
Q4
$511K Buy
+7,702
New +$498K 0.01% 602

Other funds holding DXCM

Curi RMB Capital's DXCM Position: Q1 2026 in Review

Curi RMB Capital increased its DexCom (DXCM) stake by 0.27% in Q1 2026, buying an estimated $1.46K and bringing the position to 7,723 shares worth $485K. The position accounts for 0.01% of the portfolio, ranked #609.

Curi RMB Capital first reported a position in DXCM in Q4 2025 and has held it in 2 quarters since. The position peaked at $511K in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Curi RMB Capital held 7,723 shares of DexCom worth $485K as of Q1 2026.
  • Curi RMB Capital bought 21 DexCom shares in Q1 2026, an estimated $1.46K.
  • DexCom made up 0.01% of Curi RMB Capital's portfolio in Q1 2026, its #609 holding.
  • Curi RMB Capital first reported a position in DexCom in Q4 2025 and has held it in 2 quarters since.
  • Curi RMB Capital's DexCom position peaked at $511K in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Curi RMB Capital's 13F filing for Q1 2026, filed 15 May 2026.